Home Pharmacy
The National Institutes of Health has launched a new website with educational resources for hospital employees

Workers at Risk for COVID-19 Exposure Can Access Online Training

The National Institute of Environmental Health Sciences launched virtual training website to protect workers
For relatively healthy older individuals

Daily Low-Dose Aspirin Does Not Cut Dementia Risk in Seniors

Risks for dementia, probable Alzheimer disease, MCI not reduced by low-dose aspirin versus placebo
Proton pump inhibitor use in children is associated with a small but significant increased risk for any fracture

Proton Pump Inhibitors May Up Fracture Risk in Children

Small but significant risk seen for upper-limb and lower-limb fractures
One in 10 older adults hospitalized for common medical conditions are discharged with intensified diabetes medications

Many Older Adults Receive Inpatient Diabetes Rx Intensification

Benefit unlikely in half due to limited life expectancy or already being at their HbA1c goal
National health expenditures are projected to increase at an average annual rate of 5.4 percent for 2019 to 2028

National Health Spending Expected to Increase Through 2028

National health expenditures expected to represent 19.7 percent of gross domestic product by 2028
Certain types of EpiPens and their generic counterparts may fail or delay injection of lifesaving epinephrine for severe allergic reactions

FDA Warns of Defective EpiPen Dangers

Devices may activate prematurely if the blue safety release is removed using sideways force
In a statement published online March 19 by the Infectious Diseases Society of America

IDSA Issues Recommendations for COVID-19 Testing

Four-tier approach prioritizes ICU patients, those with symptoms and contact with a patient or travel history
Inhibition of interleukin-1β with canakinumab is associated with reduced incident anemia as well as improved hemoglobin levels among patients with baseline anemia

Interleukin-1β Inhibition Linked to Reduced Incidence of Anemia

Among those with baseline anemia, hemoglobin levels improved with canakinumab versus placebo
Strong demand for medications that show promise as treatments for COVID-19 have led to shortages of those drugs in the United States.

Shortages Seen for Drugs That Show Promise Against COVID-19

Patients who currently rely on remdesivir or hydroxychloroquine now facing dangerous shortages
Insulin and other biologic drugs

FDA: Insulin Among Drugs Transitioned to Biological Products

New regulatory pathway for biologic drugs allows for approval of biosimilars, interchangeable versions